Law360, New York (September 15, 2010, 2:55 PM ET) -- A federal judge has thrown out a qui tam lawsuit against Pfizer Inc. and affiliate Pharmacia Corp. that accused the drugmakers of paying kickbacks to physicians and marketing the growth hormone deficiency medication Genotropin for off-label uses.
Judge Patti Saris of the U.S. District Court for the District of Massachusetts granted the pharmacies' motion for summary judgment Tuesday, ruling that the arguments of relator Dr. Peter Rost regarding off-label uses were incorrect and that the alleged kickbacks did not constitute a cause of action under the...
Pfizer Off The Hook In Genotropin Kickback Suit
To view the full article, take a free trial now.
